Clinical Trials on Copeptin Blood Levels in China

Total 8763 results

Shanghai Changzheng Hospital
CARsgen Therapeutics Co., Ltd.

Recruiting

Study of CT071 Injection in RRMM or PPCL

Multiple Myeloma | Primary Plasma Cell Leukemia

China
Nanjing IASO Biotechnology Co., Ltd.
Ruijin Hospital

Recruiting

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Plasma Cell Leukemia | Relapsed/Refractory Multiple Myeloma

China
Peng Liu
Shanghai East Hospital; Hrain Biotechnology

Unknown

Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM

Multiple Myeloma in Relapse | Multiple Myeloma Progression

China
Hangzhou Endonom Medtech Co., Ltd.

Completed

Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System

Aortic Arch; Aneurysm, Dissecting

China
RenJi Hospital

Recruiting

A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma

Insomnia | Psychological Distress | Somatic Symptoms

China
First Affiliated Hospital of Harbin Medical University

Unknown

Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD

Platelet Reactivity

China
Guangdong Second Provincial General Hospital

Not yet recruiting

To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

A Study of BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

Refractory Multiple Myeloma | Relapse Multiple Myeloma

China
The First Affiliated Hospital of Soochow University
CARsgen Therapeutics Co., Ltd.

Recruiting

A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

China
Hebei Senlang Biotechnology Inc., Ltd.

Recruiting

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Sun Yat-sen University

Recruiting

VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

Myeloma | Newly Diagnosed | High Risk

China
Nanjing Children's Hospital

Unknown

The Research of Standard Diagnosis and Treatment for Severe HSP in Children

Henoch-Schoenlein Purpura

China
Nanfang Hospital of Southern Medical University
Guangzhou First People's Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... and other collaborators

Unknown

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Multiple Myeloma | Conditioning | Autologous Hematopoietic Stem Cell Transplantation

China
The First Affiliated Hospital with Nanjing Medical...

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Sun Yat-sen University
China Food and Drug Administration

Withdrawn

Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma

Relapse/Refractory Multiple Myeloma

China
Xuanwu Hospital, Beijing

Recruiting

Blood Pressure Variability in Non-hypertensive Patients With Ischemic Cerebrovascular Disease (BPV-NhICVD)

Ischemic Cerebrovascular Disease | Blood Pressure Variability

China
LeMaitre Vascular

Active, not recruiting

Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair

Vascular Diseases

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Medtronic Cardiac Rhythm and Heart Failure

Terminated

Chronotropic Incompetence (CI) Diagnostic Algorithm in Heart Failure Patients

Heart Failure

China
Medtronic Cardiac Rhythm and Heart Failure

Completed

Assessment of AAIR Pacing Treatment for Heart Failure Patients With Chronotropic Incompetence

Heart Failure

China
Peking University People's Hospital

Terminated

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Leukemia

China
Peking University Shougang Hospital
MinDong Hospital of Ningde City

Unknown

Chinese Arteriosclerosis Series Evaluation-She Minority Study (CASE-SMS)

Vascular Disease

China
First Affiliated Hospital Xi'an Jiaotong University
Shaanxi Provincial People's Hospital; Henan Provincial People's Hospital; 521... and other collaborators

Not yet recruiting

Clinical Characteristics and Prognosis of Aortic Dissection in China (CLASSIC) (CLASSIC)

Aortic Dissection

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis

Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis(Post-PV MF) | Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)

China
Peking University

Completed

The Use of L-arginine to Mitigate the Cardiovascular Effects of Exposure to Traffic-related Air Pollution

Blood Pressure | Cardiac Ischemia

China
RenJi Hospital

Recruiting

The Safety of Dapagliflozin in Hemodialysis Patients With Heart Failure (SDHF)

Hemodialysis Complication

China
Tongji Hospital

Completed

Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults

Hypotension During Surgery

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of SHR2285 Tablets in Healthy Subjects

Thrombosis

China
Xiaodong Sun
Shanghai Zhongshan Hospital; Eye & ENT Hospital of Fudan University

Unknown

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

China
Beijing University of Chinese Medicine
Beijing Anzhen Hospital; China-Japan Friendship Hospital; Zhengzhou Hospital...

Unknown

Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure

Cardiovascular Diseases | Heart Failure

China
Shanghai 10th People's Hospital

Unknown

Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Chinese Population (SAFAR-China)

Blood Pressure | Cardiovascular Risk Factor | Overall Mortality | Cardiovascular Mortality | Cardiovascular Events | Target Organ Damage

China
Fudan University

Completed

Intervention Study on the Health Impact of Air Filters in Chinese Adults

Inflammation | Blood Pressure | Pulmonary Function | Coagulation

China
Shenzhen Pregene Biopharma Co., Ltd.

Recruiting

Clinical Study of the Safety and Efficacy of BCMA CAR-NK

Multiple Myeloma | Immunotherapy

China
Zhejiang Provincial People's Hospital
First Affiliated Hospital of Zhejiang University

Recruiting

Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL (APL)

Tumour

China
The University of Hong Kong

Recruiting

Effects of Masticatory Muscles Training Exercises on the Masticatory Performance and Rehabilitation of Stroke Patients

Mastication

China
Shanxi Bethune Hospital

Recruiting

Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM

Multiple Myeloma in Relapse

China
Shenzhen Geno-Immune Medical Institute
The Second Affiliated Hospital of Hainan Medical University

Recruiting

Universal CAR-T Cells Targeting Multiple Myeloma

Multiple Myeloma in Remission

China
Henan Cancer Hospital
The Pregene (ShenZhen) Biotechnology Company, Ltd.

Unknown

BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Myeloma

China
The First Affiliated Hospital of Soochow University

Unknown

PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia

Treatment

China
Liaoning University of Traditional Chinese Medicine
Dongzhimen Hospital, Beijing; Dalian Children's Hospital; Shenyang Hospital of...

Unknown

Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura

Purpura, Schoenlein-Henoch

China
Suzhou Municipal Hospital
The First Affiliated Hospital with Nanjing Medical University; Affiliated Hospital... and other collaborators

Recruiting

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)

Cardiovascular Diseases | Hypertension | Blood Pressure

China
Sun Yat-sen University

Recruiting

Validation of a Smartphone App for Anemia Screening Among General Population

Anemia

China
Liuhuaqiao Hospital

Unknown

Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

Drug Eluting Stent

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Anti-CD38 Antibody Treating Evans Syndrome (2023-D-ES)

Treatment | Evan Syndrome

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Entry Tear Repair :The First in Man Study of Endopatch System

Chronic Stanford B Type Aortic Dissection Proximal Tear

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects

Primary Immune Thrombocytopenia

China
China National Center for Cardiovascular Diseases

Not yet recruiting

CT-derived Virtual Stenting Optimize Coronary Revascularization (CT-COMPASS) (CT-COMPASS)

Percutaneous Coronary Intervention | Computed Tomography | Coronary Physiology

China
Nanfang Hospital of Southern Medical University

Recruiting

REmimazolam vs PrOpofol on Intraoperative hypotenSion in Major Noncardiac surgEry (REPOSE-1)

Intraoperative Hypotension

China
Jing Liu
HUAWEI

Not yet recruiting

Screening for Masked Hypertension With Smart Wearable Devices (SMART) (SMART)

Masked Hypertension

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Milestone Pharmaceuticals Inc.

Completed

A Study of Etripamil in Healthy Subjects

Healthy Chinese Subjects

China

Clinical Trials on Copeptin Blood Levels in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations